AMD announced its first life sciences collaboration with AI-based drug developer Absci, providing its hardware and software for Absci’s AI drug discovery. Despite AMD also investing $20m in Absci, its shares fell 4% after HSBC analyst Frank Lee downgraded the firm from “Buy” to “Reduce” and cut its price target by 18%, suggesting AMD will continue trailing market leader Nvidia. This is AMD’s first life-sciences partnership.
Malware scams cost Singaporeans S$625,000 since December 2024
Since December 2024, Singaporean authorities have received reports of 82 malware scams, with victims losing over S$625,000. The scams involved fraudulent ads for travel and
